nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—periosteum—cleft lip	0.0548	0.136	CbGeAlD
Minocycline—MMP9—periosteum—cleft lip	0.0457	0.113	CbGeAlD
Minocycline—IL1B—cartilage tissue—cleft lip	0.0384	0.095	CbGeAlD
Minocycline—MMP9—cartilage tissue—cleft lip	0.032	0.0792	CbGeAlD
Minocycline—CASP3—tongue—cleft lip	0.029	0.0718	CbGeAlD
Minocycline—CYCS—mouth—cleft lip	0.0228	0.0564	CbGeAlD
Minocycline—CASP3—mouth—cleft lip	0.0195	0.0483	CbGeAlD
Minocycline—CYCS—embryo—cleft lip	0.0162	0.0402	CbGeAlD
Minocycline—IL1B—mouth—cleft lip	0.0156	0.0386	CbGeAlD
Minocycline—CASP3—embryo—cleft lip	0.0139	0.0344	CbGeAlD
Minocycline—CYCS—telencephalon—cleft lip	0.0132	0.0327	CbGeAlD
Minocycline—MMP9—mouth—cleft lip	0.013	0.0321	CbGeAlD
Minocycline—CASP3—telencephalon—cleft lip	0.0113	0.028	CbGeAlD
Minocycline—IL1B—embryo—cleft lip	0.0111	0.0275	CbGeAlD
Minocycline—MMP9—embryo—cleft lip	0.00927	0.0229	CbGeAlD
Minocycline—IL1B—telencephalon—cleft lip	0.00904	0.0224	CbGeAlD
Minocycline—VEGFA—telencephalon—cleft lip	0.00889	0.022	CbGeAlD
Minocycline—CASP1—head—cleft lip	0.00855	0.0211	CbGeAlD
Minocycline—CYCS—head—cleft lip	0.00823	0.0204	CbGeAlD
Minocycline—CASP3—head—cleft lip	0.00705	0.0174	CbGeAlD
Minocycline—CASP1—MAPK Signaling Pathway—TGFB3—cleft lip	0.00659	0.0111	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—EPHA3—cleft lip	0.00629	0.0106	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—NODAL—cleft lip	0.00602	0.0101	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—MTR—cleft lip	0.00597	0.01	CbGpPWpGaD
Minocycline—IL1B—head—cleft lip	0.00563	0.0139	CbGeAlD
Minocycline—CASP3—Apoptosis—TP63—cleft lip	0.00549	0.00922	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—EPHA3—cleft lip	0.00546	0.00916	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP63—cleft lip	0.00528	0.00887	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB3—cleft lip	0.00496	0.00833	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—SPRY2—cleft lip	0.00491	0.00824	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—MTR—cleft lip	0.00486	0.00815	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB3—cleft lip	0.00473	0.00794	CbGpPWpGaD
Minocycline—MMP9—head—cleft lip	0.00469	0.0116	CbGeAlD
Minocycline—VEGFA—NOTCH1 regulation of human endothelial cell calcification—FGFR3—cleft lip	0.00469	0.00787	CbGpPWpGaD
Minocycline—MMP9—Angiogenesis—FGFR2—cleft lip	0.00466	0.00781	CbGpPWpGaD
Minocycline—VEGFA—Heart Development—FGF8—cleft lip	0.00463	0.00778	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB3—cleft lip	0.00455	0.00764	CbGpPWpGaD
Minocycline—VEGFA—Heart Development—BMP4—cleft lip	0.00447	0.00751	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TGFA—cleft lip	0.00444	0.00746	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IRF6—cleft lip	0.00438	0.00735	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—FGF8—cleft lip	0.00432	0.00725	CbGpPWpGaD
Minocycline—CASP3—Syndecan-2-mediated signaling events—FGFR3—cleft lip	0.00427	0.00717	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—BMP4—cleft lip	0.00417	0.007	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB3—cleft lip	0.00412	0.00691	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—FGFR2—cleft lip	0.00404	0.00678	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—MTR—cleft lip	0.00386	0.00648	CbGpPWpGaD
Minocycline—ALOX5—head—cleft lip	0.00371	0.00918	CbGeAlD
Minocycline—MMP9—Endochondral Ossification—PTCH1—cleft lip	0.00355	0.00596	CbGpPWpGaD
Minocycline—VEGFA—Glypican 1 network—FGFR1—cleft lip	0.00353	0.00593	CbGpPWpGaD
Minocycline—MMP9—Syndecan-4-mediated signaling events—FGFR1—cleft lip	0.00345	0.00579	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—TYMS—cleft lip	0.00334	0.00561	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00331	0.00555	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—MTR—cleft lip	0.00326	0.00547	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—MTHFR—cleft lip	0.0032	0.00537	CbGpPWpGaD
Minocycline—MMP9—Angiogenesis—FGF2—cleft lip	0.00317	0.00532	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB3—cleft lip	0.00317	0.00532	CbGpPWpGaD
Minocycline—MMP9—Angiogenesis—NOS3—cleft lip	0.00313	0.00525	CbGpPWpGaD
Minocycline—VEGFA—Heart Development—FGF10—cleft lip	0.0031	0.00521	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—PTCH1—cleft lip	0.00308	0.00517	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—SUMO1—cleft lip	0.003	0.00504	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—MTHFR—cleft lip	0.00292	0.0049	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—FGFR3—cleft lip	0.0029	0.00487	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—FGF10—cleft lip	0.00289	0.00486	CbGpPWpGaD
Minocycline—MMP9—Syndecan-1-mediated signaling events—FGFR3—cleft lip	0.00284	0.00477	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—FGF2—cleft lip	0.00275	0.00462	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IRF6—cleft lip	0.00274	0.00459	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—NOS3—cleft lip	0.00271	0.00455	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—MTHFR—cleft lip	0.0026	0.00437	CbGpPWpGaD
Minocycline—VEGFA—Glypican 1 network—FGF2—cleft lip	0.00258	0.00433	CbGpPWpGaD
Minocycline—MMP9—Syndecan-4-mediated signaling events—FGF2—cleft lip	0.00252	0.00423	CbGpPWpGaD
Minocycline—SLC22A8—head—cleft lip	0.00251	0.00621	CbGeAlD
Minocycline—CYCS—AGE/RAGE pathway—NOS3—cleft lip	0.00248	0.00417	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—FGFR2—cleft lip	0.00243	0.00408	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EPHA3—cleft lip	0.00234	0.00392	CbGpPWpGaD
Minocycline—VEGFA—VEGFR1 specific signals—NOS3—cleft lip	0.00233	0.00391	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGF7—cleft lip	0.00228	0.00382	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—FGFR1—cleft lip	0.00227	0.00381	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—cleft lip	0.00221	0.00371	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB3—cleft lip	0.0022	0.0037	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB3—cleft lip	0.0022	0.00369	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00215	0.00361	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—FGFR3—cleft lip	0.00214	0.0036	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—MYC—cleft lip	0.00212	0.00357	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGF8—cleft lip	0.0021	0.00353	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—MTHFR—cleft lip	0.00207	0.00347	CbGpPWpGaD
Minocycline—MMP9—Plasma membrane estrogen receptor signaling—NOS3—cleft lip	0.00204	0.00342	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EPHA3—cleft lip	0.00203	0.0034	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—NOS3—cleft lip	0.002	0.00336	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00199	0.00335	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—FGFR1—cleft lip	0.00198	0.00332	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—FGFR1—cleft lip	0.00191	0.0032	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—SUMO1—cleft lip	0.00188	0.00315	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—FGFR3—cleft lip	0.00187	0.00314	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF7—cleft lip	0.00186	0.00313	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—MYC—cleft lip	0.00184	0.00308	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—BMP4—cleft lip	0.00177	0.00297	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—MTHFR—cleft lip	0.00174	0.00293	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF8—cleft lip	0.00172	0.00289	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—FGFR1—cleft lip	0.00172	0.00289	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGF3—cleft lip	0.00171	0.00287	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGF9—cleft lip	0.00167	0.0028	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EPHA3—cleft lip	0.00167	0.0028	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—NOS3—cleft lip	0.00164	0.00275	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—FGFR3—cleft lip	0.00162	0.00273	CbGpPWpGaD
Minocycline—CYCS—DNA Damage Response—MYC—cleft lip	0.00161	0.0027	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—MYC—cleft lip	0.00159	0.00266	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—FGF2—cleft lip	0.00158	0.00265	CbGpPWpGaD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—MYC—cleft lip	0.00155	0.00261	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF7—cleft lip	0.00154	0.00258	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—NOS3—cleft lip	0.00154	0.00258	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—MYC—cleft lip	0.00147	0.00246	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EPHA3—cleft lip	0.00145	0.00243	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—FGF2—cleft lip	0.00145	0.00243	CbGpPWpGaD
Minocycline—CASP1—Immune System—IRF6—cleft lip	0.00143	0.0024	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF8—cleft lip	0.00142	0.00238	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGF10—cleft lip	0.00141	0.00236	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.00141	0.00236	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF3—cleft lip	0.0014	0.00235	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—NOS3—cleft lip	0.00139	0.00234	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ARHGAP29—cleft lip	0.00139	0.00233	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF9—cleft lip	0.00136	0.00229	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—MYC—cleft lip	0.00136	0.00228	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—NOS3—cleft lip	0.00134	0.00225	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—FGFR1—cleft lip	0.00132	0.00221	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—MYC—cleft lip	0.0013	0.00218	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—FGF2—cleft lip	0.00127	0.00213	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—FGF2—cleft lip	0.00126	0.00211	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—MYC—cleft lip	0.00125	0.0021	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—BMP4—cleft lip	0.00123	0.00206	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—FGFR1—cleft lip	0.00119	0.002	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.00119	0.002	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—cleft lip	0.00118	0.00198	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF3—cleft lip	0.00116	0.00194	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF10—cleft lip	0.00115	0.00193	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB3—cleft lip	0.00113	0.0019	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGFR2—cleft lip	0.00113	0.0019	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF9—cleft lip	0.00113	0.00189	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00111	0.00187	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—MYC—cleft lip	0.0011	0.00184	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NODAL—cleft lip	0.00107	0.0018	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.00107	0.00179	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGFR1—cleft lip	0.00105	0.00177	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00101	0.0017	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGFR3—cleft lip	0.000995	0.00167	CbGpPWpGaD
Minocycline—CASP1—Immune System—SUMO1—cleft lip	0.00098	0.00165	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ARHGAP29—cleft lip	0.000965	0.00162	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF10—cleft lip	0.000951	0.0016	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NODAL—cleft lip	0.000932	0.00157	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGFR2—cleft lip	0.000924	0.00155	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SLC19A1—cleft lip	0.00092	0.00155	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—NOS3—cleft lip	0.000916	0.00154	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—MYC—cleft lip	0.000911	0.00153	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF7—cleft lip	0.000896	0.0015	CbGpPWpGaD
Minocycline—IL1B—Immune System—IRF6—cleft lip	0.000894	0.0015	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—MYC—cleft lip	0.00088	0.00148	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000869	0.00146	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGFR1—cleft lip	0.000861	0.00145	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00085	0.00143	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000847	0.00142	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ARHGAP29—cleft lip	0.000838	0.00141	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—MYC—cleft lip	0.000835	0.0014	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF8—cleft lip	0.000827	0.00139	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—NOS3—cleft lip	0.000821	0.00138	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGFR3—cleft lip	0.000814	0.00137	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—MYC—cleft lip	0.000799	0.00134	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—cleft lip	0.000791	0.00133	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—NOS3—cleft lip	0.000775	0.0013	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGF2—cleft lip	0.000769	0.00129	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGFR2—cleft lip	0.000763	0.00128	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TCN2—cleft lip	0.000763	0.00128	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WNT9B—cleft lip	0.000762	0.00128	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MYC—cleft lip	0.000755	0.00127	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOG—cleft lip	0.00073	0.00123	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000717	0.0012	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGFR1—cleft lip	0.000711	0.00119	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000709	0.00119	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—MYC—cleft lip	0.000685	0.00115	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ABCA4—cleft lip	0.000679	0.00114	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF3—cleft lip	0.000673	0.00113	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGFR3—cleft lip	0.000672	0.00113	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—FGF2—cleft lip	0.00067	0.00113	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF9—cleft lip	0.000657	0.0011	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—MYC—cleft lip	0.000629	0.00106	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF2—cleft lip	0.000629	0.00106	CbGpPWpGaD
Minocycline—IL1B—Immune System—SUMO1—cleft lip	0.000613	0.00103	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WNT3—cleft lip	0.000605	0.00102	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—MYC—cleft lip	0.000579	0.000973	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—MYC—cleft lip	0.000569	0.000956	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000568	0.000953	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC19A1—cleft lip	0.000567	0.000952	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF7—cleft lip	0.00056	0.00094	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF10—cleft lip	0.000554	0.00093	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—FGFR1—cleft lip	0.000541	0.000908	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WNT9B—cleft lip	0.000529	0.000888	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTR—cleft lip	0.000529	0.000887	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000523	0.000879	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF2—cleft lip	0.000519	0.000872	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF8—cleft lip	0.000517	0.000868	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—FGF10—cleft lip	0.000516	0.000866	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOG—cleft lip	0.000507	0.000851	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ABCA4—cleft lip	0.000471	0.000791	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TCN2—cleft lip	0.00047	0.000789	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—FGFR1—cleft lip	0.00047	0.000788	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—FGF2—cleft lip	0.000465	0.000781	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WNT9B—cleft lip	0.000459	0.000771	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—FGF10—cleft lip	0.000448	0.000752	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGFR2—cleft lip	0.000444	0.000746	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOG—cleft lip	0.00044	0.000739	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF3—cleft lip	0.000421	0.000706	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WNT3—cleft lip	0.00042	0.000705	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGFR1—cleft lip	0.000414	0.000695	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MYC—cleft lip	0.000413	0.000693	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF9—cleft lip	0.00041	0.000689	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ABCA4—cleft lip	0.000409	0.000687	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SPRY2—cleft lip	0.0004	0.000672	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF7—cleft lip	0.0004	0.000672	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGFR3—cleft lip	0.000391	0.000657	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—FGFR1—cleft lip	0.000386	0.000648	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF8—cleft lip	0.000369	0.00062	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WNT3—cleft lip	0.000365	0.000612	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF10—cleft lip	0.000346	0.000581	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000342	0.000574	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—FGFR1—cleft lip	0.000335	0.000562	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTCH1—cleft lip	0.000332	0.000557	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTR—cleft lip	0.000326	0.000547	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TYMS—cleft lip	0.000324	0.000544	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF2—cleft lip	0.000303	0.000508	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF3—cleft lip	0.000301	0.000505	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF9—cleft lip	0.000293	0.000492	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—cleft lip	0.000283	0.000475	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—FGF2—cleft lip	0.000282	0.000473	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF7—cleft lip	0.000278	0.000466	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SPRY2—cleft lip	0.000278	0.000466	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGFR2—cleft lip	0.000278	0.000466	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGFR1—cleft lip	0.000259	0.000435	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF8—cleft lip	0.000256	0.00043	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF10—cleft lip	0.000247	0.000415	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—FGF2—cleft lip	0.000245	0.000411	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGFR3—cleft lip	0.000245	0.000411	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SPRY2—cleft lip	0.000241	0.000405	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF7—cleft lip	0.000241	0.000405	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS3—cleft lip	0.000237	0.000397	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTCH1—cleft lip	0.00023	0.000386	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF8—cleft lip	0.000223	0.000374	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF3—cleft lip	0.000209	0.00035	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF9—cleft lip	0.000203	0.000342	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTCH1—cleft lip	0.0002	0.000335	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TYMS—cleft lip	0.0002	0.000335	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGFR2—cleft lip	0.000198	0.000333	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—cleft lip	0.000197	0.000331	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF2—cleft lip	0.000189	0.000317	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGFR1—cleft lip	0.000185	0.00031	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF3—cleft lip	0.000181	0.000304	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF9—cleft lip	0.000177	0.000297	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGFR3—cleft lip	0.000175	0.000293	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—cleft lip	0.000174	0.000293	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF10—cleft lip	0.000172	0.000288	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF10—cleft lip	0.000149	0.00025	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGFR2—cleft lip	0.000138	0.000231	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF2—cleft lip	0.000135	0.000227	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—cleft lip	0.000133	0.000224	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGFR1—cleft lip	0.000128	0.000215	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—cleft lip	0.000122	0.000204	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGFR3—cleft lip	0.000121	0.000204	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGFR2—cleft lip	0.00012	0.000201	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGFR1—cleft lip	0.000111	0.000187	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGFR3—cleft lip	0.000105	0.000177	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF2—cleft lip	9.38e-05	0.000157	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—cleft lip	9.25e-05	0.000155	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—cleft lip	8.83e-05	0.000148	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF2—cleft lip	8.14e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—cleft lip	8.03e-05	0.000135	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—cleft lip	6.13e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—cleft lip	5.32e-05	8.93e-05	CbGpPWpGaD
